EXoPERT is a biotech company focusing on detecting cancer early by liquid biopsy. Founded in 2018, EXoPERT is developing a Novel Liquid biopsy technology that detects cancer at an early stage, and we aim to expand our impact in healthcare through continued research and development. We are using our exosome platform to detect serious diseases early by a single draw of blood. For more information, please visit exopert.com.
| Website | https://www.exopert.com/ |
| Employees | 14 (4 on RocketReach) |
| Founded | 2018 |
| Phone | +82 2-923-8833 |
| Industry | Biotechnology Research |
| Keywords | Liquid Biopsy, Early Cancer Detection, Cancer Diagnostics, Biotechnology, Medical Diagnostics, Precision Oncology, Cancer Research, Novel Diagnostics, Biomarker Discovery, Healthcare Technology, Molecular Diagnostics, Oncology Diagnostics, Cancer Screening, Disease Diagnostics, Biomedical Technology, Diagnostic Testing, Clinical Diagnostics, Medical Technology, Health Diagnostics, In-Vitro Diagnostics |
Looking for a particular EXoPERT employee's phone or email?
EXoPERT Questions
Hyunku Shin is the CTO of EXoPERT.
4 people are employed at EXoPERT.
Top EXoPERT Employees
G2Crowd Trusted
300K+
Plugin Users
